natgillin/translations-raw huggingface dataset:
Blister packs of 10 tablets per strip composed of PVC/PVDC base foil and aluminium lidding foil in cartons containing 10, 20, 100 or 500 tablets.
Pretisni omoti po 10 tablet na traku (PVC/PVDC bazna folija in prekrivna folija iz aluminija), pakirani v škatle po 10, 20, 100 ali 500 tablet.
To be supplied on veterinary prescription.
Na veterinarski recept.
Carton Box labelling
Kartonska škatla
For dogs weighing less than 4 kg the use of meloxicam containing oral suspension for dogs is recommended.
Za pse z manjšo telesno maso od 4 kg priporočamo uporabo peroralne suspenzije za pse, ki vsebuje meloksikam.
Reduction of post-operative pain in cats when administration of meloxicam is to be continued as an oral follow-up therapy:
Lajšanje pooperativne bolečine pri mačkah, kjer se bo dajanje meloksikama nadaljevalo v obliki peroralnega nadaljevalnega zdravljenja:
For use in diarrhoea in combination with oral re-hydration therapy to reduce clinical signs in calves of over one week of age and young, non-lactating cattle.
Za umirjanje kliničnih znakov driske, v kombinaciji s peroralnim rehidracijskim zdravljenjem, pri teletih, starejših od enega tedna, in mladih govedih, ki niso v obdobju laktacije.
Do not use in animals less than 6 weeks of age nor in cats of less than 2 kg.
Ne uporabite pri živalih, mlajših od 6 tednov, niti pri mačkah, lažjih od 2 kg.
Antiinflammatory agents/ Nonsteroidal antiinflammatory agents
Protivnetna zdravila/ Nesteroidna protivnetna zdravila
The oral follow-up dose may be administered for up to a total of four doses at 24 hour intervals.
Peroralni nadaljevalni odmerek se lahko da največ štiri krat v 24-urnih intervalih.
Detailed information on this product is available on the website of the European Medicines Agency http://www.ema.europa.eu/.
Podrobne informacije o tem zdravilu so na voljo na spletni strani Evropske agencije za zdravila (European Medicines Agency) http://www.ema.europa.eu/.
The following clinical signs (some of which may be serious) have been reported in clinical studies following administration of the product at 5x overdose: dull behaviour, diarrhoea, oedema, buccal mucosal ulceration and/or dark coloured urine.
V kliničnih študijah so po 5-kratnem prekomernem odmerjanju zdravila poročali o naslednjih kliničnih znakih (nekateri so lahko resni): otopelost, driska, edem, razjeda bukalne sluznice in/ali temno obarvan urin.
Use during pregnancy and lactation: Do not use in pregnant or lactating mares
Uporaba v obdobju brejosti in laktacije: Ne uporabite pri brejih kobilah ali kobilah v obdobju laktacije.
Pale yellow suspension.
Bledo rumena suspenzija.
After two intramuscular doses of 0.4 mg meloxicam/kg, a Cmax value of 1.9 μg/ml was reached after 1 hour in pigs.
Po dveh intramuskularnih odmerkih meloksikama po 0,4 mg/kg je bila dosežena Cmax pri prašičih po 1 uri 1,9 µg/ml.
Cattle: Single subcutaneous or intravenous injection.
Govedo: Enkratna podkožna ali intravenska injekcija.
EXP {month/year} Shelf-life of the halved tablet: 24-hours
EXP mesec/leto Rok uporabnosti prepolovljene tablete: 24 ur
QUANTITY OF THE ACTIVE SUBSTANCE
KOLIČINA UČINKOVINE
Loxicom 0.5 mg/ml Oral Suspension for Cats is to be administered orally either mixed with food or directly into the mouth.
Loxicom 0,5 mg/ml peroralno suspenzijo za mačke dajemo peroralno, s hrano ali direktno v usta.
Pharmacotherapeutic group: Anti-inflammatory and antirheumatic products, non-steroids (oxicams) ATC vet code: QM01AC06
Farmakoterapevtska skupina: Nesteroidna protivnetna in protirevmatična zdravila (oksikami) Oznaka ATC vet: QM01AC06
Alternatively, therapy may be initiated with a solution for injection containing 5 mg meloxicam/ml.
Alternativno, lahko prvi dan zdravljenja uporabite raztopino za injiciranje, ki vsebuje 5 mg meloksikama/ml.
EXP {month/year} Once broached, use by …
EXP {mesec/leto} Načeto zdravilo uporabite do…
Administration of the veterinary medicinal product by the subcutaneous route in cattle and the intramuscular route in pigs is well tolerated; only a slight transient swelling at the injection site following subcutaneous administration was observed in less than 10 % of cattle treated in clinical studies.
Subkutano dajanje zdravila pri govedu in intramuskularno pri prašičih živali dobro prenašajo; pri govedu, zdravljenih v kliničnih raziskavah so pri manj kot 10 % živali opazili le blago prehodno oteklino na mestu po subkutanem injiciranju.
Meloxicam also has anti-endotoxic properties because it has been shown to inhibit production of thromboxane B2 induced by intravenous E. coli endotoxin administration in calves and pigs.
Meloksikam deluje tudi antiendotoksično, saj so dokazali, da zavira nastajanje tromboksana B2, izzvano z intravenskim vnosom endotoksina E.coli pri teletih in prašičih.
Alternatively therapy may be initiated with Loxicom 5 mg/ml solution for injection.
Alternativna terapija je dajanje Loxicom 5 mg/ml raztopine za injiciranje.
MARKETING AUTHORISATION NUMBERS:
ŠTEVILKE DOVOLJENJ ZA PROMET:
A. MANUFACTURER RESPONSIBLE FOR BATCH RELEASE
A. PROIZVAJALEC ZDRAVILA ODGOVOREN ZA SPROŠČANJE SERIJ
See section 4.10.
Glejte poglavje 4.10.
In the case of overdose, adverse reactions (as listed in Section 4.6) are expected to be more severe and more frequent.
Pri prevelikem odmerjanju lahko pričakujemo resnejše in pogostejše neželene reakcije, opisane v poglavju 4.6.
Interaction with other medicinal products and other forms of interaction: Do not administer concurrently with glucocorticosteroids, other non-steroidal anti-inflammatory drugs or with anti-coagulant agents.
Medsebojno delovanje z drugimi zdravili in druge oblike interakcij: Ne uporabite sočasno z glukokortikosteroidi, drugimi nesteroidnimi protivnetnimi zdravili ali antikoagulantnimi sredstvi.
Shelf-life of the halved tablet: 24-hours
Rok uporabnosti prepolovljene tablete: 24 ur.
Approximately 75% of the administered dose is eliminated via faeces and the remainder via urine.
Približno 75 % vnesenega odmerka se izloči z blatom, preostanek pa z urinom.
Do not use in cases of hypersensitivity to the active substance or to any of the excipients.
Ne uporabite v primerih preobčutljivosti na učinkovino ali na katero koli pomožno snov.
Chewable tablet.
Žvečljiva tableta.
In case of overdose, adverse reactions, as listed in section "Adverse reactions", are expected to be more severe and more frequent.
Pri prevelikem odmerjanju se lahko pričakujejo resnejši in pogostejši neželeni učinki, opisani v poglavju »Neželeni učinki«.
Each syringe delivers 420 mg meloxicam, sufficient to treat 700 kg of bodyweight.
Vsaka brizga vsebuje 420 mg meloksikama, kar zadošča za zdravljenje konja s telesno maso 700 kg.
Number of chewable tablets 2.5 mg mg/kg
Število žvečljivih tablet 2,5 mg mg/kg
For initiation of the treatment of acute musculo-skeletal disorders on the first day, 4 times the maintenance volume will be required.
Za zdravljenje akutnih mišično-skeletnih obolenj pa je prvi dan potreben 4kratni volumen vzdrževalnega odmerka.
Post-operative pain: single intravenous or subcutaneous injection.
Pooperativna bolečina: enkratno intravensko ali podkožno dajanje.
Pigs: Single intramuscular injection.
Prašiči: Enkratna intramuskularna injekcija.
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Drugi NSAR, diuretiki, antikoagulanti, aminoglikozidni antibiotiki in snovi z visoko vezavo na beljakovine se lahko kompetitivno vežejo, kar lahko privede do toksičnih učinkov.
Pigs: Meat and offal: 5 days Horses: Meat and offal:
Govedo: Meso in organi: 15 dni; Mleko: 5 dni Prašiči: Meso in organi: 5 dni
Shelf-life after first opening the container: 6 months.
Rok uporabnosti po prvem odpiranju vsebnika: 6 mesecev.
Colourless glass injection vial of 10, 20 or 100 ml, closed with a bromobutyl stopper and sealed with an aluminium cap.
Brezbarvna steklena viala po 10 ml, 20 ml ali 100 ml, zaprta z bromobutilnim zamaškom in aluminijasto zaporko.
In case of inadequate relief of pain when used in the treatment of equine colic, careful re-evaluation of the diagnosis should be made as this could indicate the need for surgical intervention.
V primeru, da pri konjih bolečine povezane s koliko ne prenehajo, moramo ponovno skrbno preveriti diagnozo, ker je morda indiciran kirurški poseg.
50 mg/g Benzyl alcohol 10 mg/g
Meloksikam 50 mg/g Benzilalkohol 10 mg/g
In very rare cases loss of appetite, lethargy, abdominal pain and colitis have been reported.
Zelo redko so poročali o izgubi apetita, letargiji, bolečini v trebuhu in kolitisu.
When the product is used according to the recommended dosage regime, steady state concentrations of meloxicam in plasma are reached on the second day of treatment.
Če se zdravilo daje po priporočeni shemi odmerjanja, doseže meloksikam ustaljene koncentracije v plazmi drugi dan zdravljenja.
Cats: Post-operative pain: single subcutaneous injection.
Mačke: Pooperativna bolečina: enkratno podkožno dajanje.
For any information about this veterinary medicinal product, please contact the local representative of the marketing authorisation holder.
Za vse nadaljne informacije o tem zdravilu se obrnite na krajevno predstavništvo imetnika dovoljenja za promet z zdravilom.
Not authorised for use in animals producing milk for human consumption.
3 dni Ni dovoljena uporaba pri živalih, katerih mleko je namenjeno prehrani ljudi.
Muscle Liver Kidney
Mišice Jetra Ledvice
Meloxicam is eliminated with a half-life of 26 hours and 17.5 hours after subcutaneous injection in young cattle and lactating cows, respectively.
Razpolovna doba izločanja meloksikama je po podkožni injekciji pri mladih govedih in kravah v obdobju laktacije 26 in 17,5 ure.
Meglumine
Brizga
In horses, a transient swelling at the injection site can occur but resolved without intervention.
Pri konjih se lahko na mestu dajanja pojavi prehodna oteklina, ki spontano izgine.
Not authorised for use in horses producing milk for human consumption.
Ni dovoljena uporaba pri kobilah, katerih mleko je namenjeno prehrani ljudi.
The veterinary medicinal product is available in polyethylene terephthalate bottle of 15 and 30 ml with two (1 ml and a 5 ml syringe, are supplied with each bottle to ensure accurate dosing of small and large dogs) polyethylene/polypropylene measuring syringes.
Zdravilo je na razpolago v polietilen-tereftalat plastenkah po 15 ml in 30 ml s priloženima dvema (za natančno odmerjanje pri majhnih in velikih psih sta vsaki plastenki priloženi 1 ml in 5 ml brizga) polietilensko/polipropilenskima merilnima brizgama.
Following subcutaneous administration, meloxicam is completely bioavailable and maximal mean plasma concentrations of 0.73 µg/ml in dogs and 1.1 µg/ml in cats were reached approximately 2.5 hours and 1.5 hours post-administration, respectively.
Meloksikam je po podkožnem dajanju v celoti biološko uporaben in doseže največjo srednjo koncentracijo v plazmi, ki je 0,73 μg/ml pri psih in 1,1 μg/ml pri mačkah, približno 2,5 ure oz. 1,5 ure po dajanju.
Each chewable tablet can be halved for accurate dosing according to the individual body weight of the animal.
Žvečljivo tableto lahko razpolovite, da odmerek natančno prilagodite telesni masi živali.
Horses: Single intravenous injection.
Konji: Enkratna intravenska injekcija.
Administration of the product by the subcutaneous route in cattle and the intramuscular route in pigs is well tolerated; only a slight transient swelling at the injection site following subcutaneous administration was observed in cattle treated in clinical studies.
Subkutano dajanje zdravila pri govedu in intramuskularno pri prašičih živali dobro prenašajo; pri govedu, zdravljenih v kliničnih raziskavah so opazili le blago prehodno oteklino na mestu po subkutanem injiciranju.
A suitably graduated 1 ml syringe should be used for administration of the product to cats.
Pri dajanju zdravila mačkam je treba uporabiti ustrezno graduirano 1 ml brizgo.
Musculo-skeletal disorders: single subcutaneous injection.
Mišično-skeletna obolenja: enkratno podkožno dajanje.
To ensure administration of a correct dose, body weight should be determined as accurately as possible.
Za zagotavljanje predpisanega odmerka je treba čimbolj natančno določiti telesno maso živali.
Each chewable tablet contains either 1 mg or 2.5 mg meloxicam, which corresponds to the daily maintenance dose for a 10 kg body weight dog or a 25 kg body weight dog, respectively.
Vsaka žvečljiva tableta vsebuje 1 mg ali 2,5 mg meloksikama, kar ustreza dnevnemu vzdrževalnemu odmerku za psa s telesno maso 10 kg oziroma 25 kg.
These side effects are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Našteti neželeni učinki so večinoma prehodni in po končanem zdravljenju minejo, vendar so lahko v zelo redkih primerih tudi resni ali smrtno nevarni.
EXP: Shelf-life of opened bottle: 6 months.
Exp: Rok uporabnosti odprte plastenke: 6 mesecev.
Other non-steroidal anti-inflammatory drugs (NSAIDs), diuretics, anticoagulants, aminoglycoside antibiotics and substances with high protein binding may compete for binding and thus lead to toxic effects.
Druga nesteroidna protivnetna zdravila (NSAID), diuretiki, antikoagulanti, aminoglikozidni antibiotiki in snovi z visoko vezavo na beljakovine se lahko kompetitivno vežejo, kar lahko privede do toksičnih učinkov.
To continue treatment for up to five days, this initial dose may be followed 24 hours later by administration of Loxicom 0.5 mg/ml oral suspension for cats at a dosage of 0.05 mg meloxicam/kg body weight.
Za nadaljevanje zdravljenja do največ pet dni, lahko temu začetnemu odmerku 24 ur kasneje sledi dajanje Loxicom 0,5 mg/ml peroralne suspenzije za mačke v odmerku 0,05 mg meloksikama/kg telesne mase.
When anaesthesia and NSAID are concomitantly administered, a risk for renal function cannot be excluded.
Kadar med anestezijo dajemo nesteroidna protivnetna zdravila, ni možno izključiti škodljivih učinkov na delovanje ledvic.
These adverse reactions occur generally within the first treatment week and are in most cases transient and disappear following termination of the treatment but in very rare cases may be serious or fatal.
Našteti neželeni učinki so najpogostnejši prvi teden zdravljenja, so večinoma prehodni in po končanem zdravljenju minejo, vendar so lahko v zelo redkih primerih tudi resni ali smrtno nevarni.
Thus for the first day, twice the maintenance volume will be required.
Prvi dan zdravljenja je torej potreben dvakratni volumen vzdrževalnega odmerka.
For use in acute respiratory infection with appropriate antibiotic therapy to reduce clinical signs in cattle.
Za umirjanje kliničnih znakov pri akutnih okužbah dihal pri govedih ob ustreznem antibiotičnem zdravljenju.
Horses: Meat and offal: 3 days.
Konji: Meso in organi: 5 dni
If the animal is fasted when dosed, the maximal plasma concentrations are obtained after approximately 3 hours.
Če prejme žival odmerek na tešče, doseže meloksikam največje koncentracije v plazmi približno po 3 urah.
Do not use in cats less than 6 weeks old.
Ne uporabite pri mačkah, mlajših od 6 tednov.
Alleviation of mild to moderate post-operative pain and inflammation following surgical procedures in cats, e.g. orthopaedic and soft tissue surgery.
Umirjanje blage do zmerne pooperativne bolečine in vnetja po kirurških posegih pri mačkah, kot so ortopedske operacije in operacije mehkih tkiv.
After a single subcutaneous dose of 0.5 mg meloxicam/kg, Cmaxvalues of 2.1 μg/ml and 2.7 μg/ml were reached after 7.7 hours and 4 hours in young cattle and lactating cows, respectively.
Po enkratnem podkožnem odmerku meloksikama po 0,5 mg/kg je bila dosežena Cmax pri mladih govedih in kravah v obdobju laktacije 2,1 µg/ml in 2,7 µg/ml po 7,7 ure in 4 urah.
EXP {month/year} Shelf life of broached vial: 28 Days Once broached, use by …
Rok uporabnosti odprte viale: 28 dni Načeto/odprto zdravilo uporabite do…
For longer term treatment, once clinical response has been observed (after ≥ 4 days), the dose can be adjusted to the lowest effective individual dose reflecting that the degree of pain and inflammation associated with chronic musculo-skeletal disorders may vary over time.
Pri dolgotrajnem zdravljenju, ko je dosežen klinični odziv (po 4 dneh), lahko odmerek individualno zmanjašamo na najnižji še učinkovit odmerek.
MARKETING AUTHORISATION NUMBER
ŠTEVILKA DOVOLJENJA ZA PROMET
Each chewable tablet contains:
KAKOVOSTNA IN KOLIČINSKA SESTAVA Vsaka žvečljiva tableta vsebuje:
Treatment is to be continued once daily by oral administration (at 24-hour intervals) at a dose of 0.05 mg meloxicam/kg body weight for as long as acute pain and inflammation persist.
Zdravljenje nadaljujemo enkrat dnevno (v 24 urnih presledkih) s peroralnim odmerkom po 0,05 mg meloksikama/kg telesne mase tako dolgo, dokler traja akutna bolečina in vnetje.
Therefore the use in this species is not recommended during pregnancy and lactation.
Za konje podatkov ni na razpolago, zato pri tej živalski vrsti uporaba v obdobju brejosti in laktacije ni priporočljiva.
In cats, Loxicom 0.5 mg/ml oral suspension for cats should be used.
Pri mačkah je treba uporabiti Loxicom 0,5 mg/ml peroralno suspenzijo za mačke.
Horses: Acute and chronic musculo-skeletal disorders.
Konji: Akutna in kronična mišično-skeletna obolenja.
One gram contains:
KAKOVOSTNA IN KOLIČINSKA SESTAVA En gram vsebuje:
Do not use in pregnant or lactating cats.
Ne uporabite pri brejih mačkah in mačkah v obdobju laktacije.
Thus for initiation of the treatment of chronic musculo-skeletal disorders on the first day, twice the maintenance volume will be required.
Za zdravljenje kroničnih mišično-skeletnih obolenj je prvi dan potreben dvakratni volumen vzdrževalnega odmerka.
Loxicom must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Loxicom ne smemo dajati sočasno z drugimi NSAR ali glukokortikosteroidi.
Concurrent administration of potential nephrotoxic drugs should be avoided.
Sočasnemu dajanju potencijalno nefrotoksičnih zdravil se je treba izogibati.
Reduction of post-operative pain (over a period of 24 hours): Single intravenous or subcutaneous injection at a dosage of 0.2 mg meloxicam/kg bodyweight (i.e. 0.4 ml/10 kg bodyweight) before surgery, for example at the time of induction of anaesthesia.
Lajšanje pooperativne bolečine (v 24 urnem obdobju): enkratno intravensko ali podkožno dajanje 0,2 mg meloksikama na kilogram telesne mase (to je 0,4 ml/10 kg telesne mase) pred operacijo, naprimer ob indukciji anestezije.
Low-density polyethylene pre-filled syringes containing 8.4 g of product in cartons of 1, 7, or 14 syringes.
Že napolnjene brizge iz polietilena nizke gostote, vsaka vsebuje 8,4 g zdravila.
Single administration of 0.3 mg meloxicam/kg bodyweight (i.e. 0.06 ml/kg) where no oral follow-up treatment is possible e.g. feral cats.
Enkratno dajanje 0,3 mg meloksikama/kg telesne mase (to je 0,06 ml/kg), kadar zdravljenja ni mogoče nadaljevati peroralno npr. divje mačke.
The suspension should be given using the Loxicom measuring syringe provided in the package.
Suspenzijo je treba odmeriti z merilno brizgo za Loxicom, ki je sestavni del pakiranja.
Cattle, pigs and horses
CILJNE ŽIVALSKE VRSTE Govedo, prašiči in konji
Carton box 10, 32, 100, 2 x 100 ml and 200 ml bottle
Kartonska škatla 10, 32, 100 ml, 2 x 100 ml in 200 ml plastenka
The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose of 0.05 mg meloxicam/kg body weight.
Brizga je oblikovana tako, da se prilega plastenki in ima merilno skalo z oznakami telesne mase v kilogramih, ki ustrezajo vzdrževalnemu odmerku 0,05 mg meloksikama/kg telesne mase.
After initial treatment with Loxicom 5 mg/ml solution for injection for dogs and cats continue treatment 24 hours later with Loxicom 0.5 mg/ml oral suspension for cats at a dosage of 0.05 mg meloxicam/kg body weight.
Po začetnem zdravljenju z Loxicom 5 mg/ml raztopino za injiciranje za pse in mačke, zdravljenje po 24 urah nadaljujemo z Loxicom 0,5 mg/ml peroralno suspenzijo za mačke v odmerku 0,05 mg meloksikama/kg telesne mase.
A yellow solution.
Rumena raztopina.
TARGET SPECIES
CILJNI ŽIVALSKI VRSTI
Approximately 50% of the administered dose is eliminated via urine and the remainder via faeces.
Približno 50 % vnesenega odmerka se izloči s sečem, preostanek pa z blatom.
Shelf-life of the veterinary medicinal product as packaged for sale: 18 months.
Rok uporabnosti zdravila v pakiranju za prodajo: 18 mesecev.
Acute and chronic musculo-skeletal disorders.
Akutna in kronična mišično-skeletna obolenja.
In very rare cases (less than 1 animal in 10,000 animals treated, including isolated reports), anaphylactoid reactions may occur and should be treated symptomatically.
Zelo redko (pri manj kot 1 živali od 10.000 zdravljenih živali, vključno s posameznimi primeri) se lahko pojavijo anafilaktoidne reakcije, ki jih je treba zdraviti simptomatsko.
The veterinary medicinal product is presented in 10 ml, 32 ml, 100 ml, 2 x 100 ml and 200 ml polyethylene terephthalate screw bottles with HDPE/LDPE child resistant caps.
Zdravilo za uporabo v veterinarski medicini je pakirano v polietilen-tereftalat plastenke po 10 ml, 32 ml, 100 ml, 2 x 100 ml in 200 ml, z HDPE/LDPE za otroke varnim zapiralom.
In cats, a meloxicam containing oral suspension authorised for that species should be used.
Pri mačkah uporabite za mačke odobreno peroralno suspenzijo, ki vsebuje meloksikam.
The syringe fits onto the bottle and has a kg-body weight scale which corresponds to the maintenance dose.
Brizga je oblikovana tako, da se prilega plastenki in ima merilno skalo z oznakami telesne mase v kilogramih, ki ustrezajo vzdrževalnemu odmerku.
Initial treatment is a single dose of 0.2 mg meloxicam/kg body weight on the first day, which can be given orally or alternatively using meloxicam 5 mg/ml solution for injection for dogs and cats.
Začetni odmerek prvi dan zdravljenja je 0,2 mg meloksikama na kilogram telesne mase, ki se ga da peroralno ali pa se uporabi meloksikam 5 mg/ml raztopino za injiciranje za pse in mačke.
Any unused medicines or waste materials should not be disposed of via wastewater or household waste but in accordance with local requirements.
Vsako neporabljeno zdravilo ali odpadne snovi je treba odstraniti v skladu z lokalnimi zahtevami in jih ne odvrzite v odpadno vodo ali v gospodinjske odpadke.
If adverse effects occur, treatment should be discontinued and the advice of a veterinarian should be sought.
Če se pojavijo neželeni učinki, je treba zdravljenje ukiniti in se posvetovati z veterinarjem.
Post-operative pain and inflammation following surgical procedures:
Pooperativna bolečina in vnetje po kirurških posegih:
Single subcutaneous or intravenous injection at a dosage of 0.5 mg meloxicam/kg body weight (i.e., 2.5 ml/100 kg body weight) in combination with antibiotic therapy or with oral re-hydration therapy, as appropriate.
Enkratna podkožna ali intravenska injekcija odmerka po 0,5 mg meloksikama na kilogram telesne mase (to je 2,5 ml/100 kg telesne mase), po potrebi v kombinaciji z antibiotičnim zdravljenjem ali s peroralno rehidracijsko terapijo.
This veterinary medicinal product must not be administered in conjunction with other NSAIDs or glucocorticosteroids.
Tega zdravila za uporabo v veterinarski medicini se ne sme dajati sočasno z drugimi nesteroidnimi protivnetnimi zdravili ali glukokortikosteroidi.
Cats: Reduction of post-operative pain after ovariohysterectomy and minor soft tissue surgery.
Mačke: Lajšanje bolečine po ovariohisterektomiji in manjših kirurških posegih na mehkih tkivih.
Store below 30 ºC.
Shranjujte pri temperaturi pod 30 °C.
Shelf-life of the veterinary medicinal product as packaged for sale: 18 months Shelf-life after first opening the immediate packaging: 6 months
Rok uporabnosti zdravila v pakiranju za prodajo: 18 mesecev Rok uporabnosti po prvem odpiranju stične ovojnine: 6 mesecev.
In cattle, meloxicam is also a major excretion product in milk and bile whereas urine contains only traces of the parent compound.
Pri govedih je tudi pomembna sestavina pri izločanju zdravila z mlekom in žolčem, medtem ko vsebuje urin samo sledi matične spojine.